Purchase Order HHSD2002014M60287P

This is a $24,570.00 firm fixed-price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) of the Department of Health and Human Services to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific. The contract is a Blanket Purchase Agreement (BPA) call order for the Expifectamine transfection kit, a reagent used for genetic engineering and cell culture applications. As the prime contractor, Life Technologies is responsible for providing the...

The National Institutes of Health, under the National Center for Advancing Translational Sciences, awarded a $1.94 million firm-fixed price purchase order to Celltrio Inc. to deliver a CellTrio Cell Line Automation System with installation and a 12-month warranty. The system, which includes an incubator, sample storage and retrieval system, microscope, cell counter, robotic handling, centrifuge, and integrated liquid handler and software, will support automated cell culture processes in NIH's...

This is a firm fixed price contract awarded by the National Institutes of Health (NIH) to Life Technologies Corporation, a division of Thermo Fisher Scientific, for the provision of a Transfection Kit in the amount of $4,766.40. The contract was awarded on February 25, 2016 with a final completion date of April 30, 2016. There was no set-aside designation used for this award. Life Technologies, as a manufacturer of scientific instruments, reagents, and consumables, has a broad portfolio of...

This federal contract award is for the purchase of 418 units of the 293FECTIN TRANSFECTION REAGENT, catalog number 12347-019, from Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific Inc. The total value of the award is $74,839.50, with a firm fixed price of $179.00 per unit. The contract was awarded on September 6, 2012, with a completion date of September 28, 2012. The contracting agency is the National Institute of Allergy and Infectious Diseases (NIAID), which is part...

This is a $4,500 firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables. The contract is for the provision of an EXPIFECTAMINE 293 TRANSFECTION KIT, a product used in genetic research and applied markets. Life Technologies, a subsidiary of Thermo Fisher Scientific, has provided specialized biotechnology products and services to support...

Life Technologies Corporation, doing business as Thermo Fisher Scientific, received a firm fixed price contract award from the National Center for Advancing Translational Sciences (NCATS) on March 11, 2014, for the supply of Lipofectamine RNAiMax reagent in 1.5 milliliter aliquots. This $24.3K contract, issued as a call against an existing Blanket Purchase Agreement (BPA) with no set-aside designation, reflects NCATS's procurement of specialized molecular biology reagents essential for...

This $9,220.00 firm fixed price contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the U.S. Department of Health and Human Services, to Life Technologies Corporation (a division of Thermo Fisher Scientific). The contract is for the delivery of the Expifectamine 293 Transfection Kit, a laboratory product used for the transfection of mammalian cells. This award was made as a Blanket Purchase Agreement (BPA) call and did not utilize...

This is a firm-fixed-price BPA call contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific, for the delivery of an EXPIFECTAMINE 293 Transfection Kit. The $7,520.00 contract supports biotechnology research and did not utilize any set-aside designations. Life Technologies Corporation has established itself as a prime contractor across multiple federal agencies, providing a wide range of...

The Department of Health and Human Services Food and Drug Administration awarded a $25,000 firm fixed price purchase order to Life Technologies Corporation for cell line engineering services utilizing the Invitrogen FLP-IN 293 cell line. Life Technologies Corporation is a subsidiary of Thermo Electron Corporation Financial Services Division and will perform the services in Silver Spring, Maryland. The contract runs from August 31, 2023 through August 30, 2024 to provide the FDA with cell line...

The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $231,000.00 firm-fixed-price purchase order to Life Technologies Corporation, a for-profit manufacturer, for the provision of EXPI293F license and cell lines. This contract does not have a set-aside designation. The products and services are to be delivered by the July 31, 2021 completion date. Life Technologies Corporation is a subsidiary of the parent company Thermo Electron Corporation, which...